120 related articles for article (PubMed ID: 18423488)
41. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
[TBL] [Abstract][Full Text] [Related]
42. Alteration of amino acid residues at the L-chain N-terminus and in complementarity-determining region 3 increases affinity of a recombinant F(ab) for the human N blood group antigen.
Song SC; Czerwinski M; Wojczyk BS; Spitalnik SL
Transfusion; 2004 Feb; 44(2):173-86. PubMed ID: 14962308
[TBL] [Abstract][Full Text] [Related]
43. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
Julien JP; Bryson S; Nieva JL; Pai EF
J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005
[TBL] [Abstract][Full Text] [Related]
44. Efficient bacterial production of functional antibody fragments using a phagemid vector.
Kuba H; Furukawa A; Okajima T; Furukawa K
Protein Expr Purif; 2008 Apr; 58(2):292-300. PubMed ID: 18077183
[TBL] [Abstract][Full Text] [Related]
45. Structure of IL-17A in complex with a potent, fully human neutralizing antibody.
Gerhardt S; Abbott WM; Hargreaves D; Pauptit RA; Davies RA; Needham MR; Langham C; Barker W; Aziz A; Snow MJ; Dawson S; Welsh F; Wilkinson T; Vaugan T; Beste G; Bishop S; Popovic B; Rees G; Sleeman M; Tuske SJ; Coales SJ; Hamuro Y; Russell C
J Mol Biol; 2009 Dec; 394(5):905-21. PubMed ID: 19835883
[TBL] [Abstract][Full Text] [Related]
46. Humanization of an anti-CD34 monoclonal antibody by complementarity-determining region grafting based on computer-assisted molecular modelling.
Hou S; Li B; Wang L; Qian W; Zhang D; Hong X; Wang H; Guo Y
J Biochem; 2008 Jul; 144(1):115-20. PubMed ID: 18424812
[TBL] [Abstract][Full Text] [Related]
47. Improving the affinity of antigens for mutated antibodies by use of statistical molecular design.
Mandrika I; Prusis P; Bergström J; Yahorava S; Wikberg JE
J Pept Sci; 2008 Jul; 14(7):786-96. PubMed ID: 18200617
[TBL] [Abstract][Full Text] [Related]
48. Construction of a fully synthetic human scFv antibody library with CDR3 regions randomized by a split-mix-split method and its application.
Yin CC; Ren LL; Zhu LL; Wang XB; Zhang Z; Huang HL; Yan XY
J Biochem; 2008 Nov; 144(5):591-8. PubMed ID: 18713799
[TBL] [Abstract][Full Text] [Related]
49. The structure of the anti-c-myc antibody 9E10 Fab fragment/epitope peptide complex reveals a novel binding mode dominated by the heavy chain hypervariable loops.
Krauss N; Wessner H; Welfle K; Welfle H; Scholz C; Seifert M; Zubow K; Aÿ J; Hahn M; Scheerer P; Skerra A; Höhne W
Proteins; 2008 Nov; 73(3):552-65. PubMed ID: 18473392
[TBL] [Abstract][Full Text] [Related]
50. In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification.
Steidl S; Ratsch O; Brocks B; Dürr M; Thomassen-Wolf E
Mol Immunol; 2008 Nov; 46(1):135-44. PubMed ID: 18722015
[TBL] [Abstract][Full Text] [Related]
51. A general method for greatly improving the affinity of antibodies by using combinatorial libraries.
Rajpal A; Beyaz N; Haber L; Cappuccilli G; Yee H; Bhatt RR; Takeuchi T; Lerner RA; Crea R
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8466-71. PubMed ID: 15939870
[TBL] [Abstract][Full Text] [Related]
52. LRP6 holds the key to the entry of anthrax toxin.
Bann JG; Cegelski L; Hultgren SJ
Cell; 2006 Mar; 124(6):1119-21. PubMed ID: 16564002
[TBL] [Abstract][Full Text] [Related]
53. Structural basis of affinity maturation of the TEPC15/Vkappa45.1 anti-2-phenyl-5-oxazolone antibodies.
Scotti C; Gherardi E
J Mol Biol; 2006 Jun; 359(5):1161-9. PubMed ID: 16682055
[TBL] [Abstract][Full Text] [Related]
54. Cloning antifungal single chain fragment variable antibodies by phage display and competitive panning elution.
Krishnaswamy S; Kabir ME; Miyamoto M; Furuichi Y; Komiyama T
Anal Biochem; 2009 Dec; 395(1):16-24. PubMed ID: 19665444
[TBL] [Abstract][Full Text] [Related]
55. Computational insights into the interaction of the anthrax lethal factor with the N-terminal region of its substrates.
Joshi M; Ebalunode JO; Briggs JM
Proteins; 2009 May; 75(2):323-35. PubMed ID: 18831046
[TBL] [Abstract][Full Text] [Related]
56. Structural classification of CDR-H3 revisited: a lesson in antibody modeling.
Kuroda D; Shirai H; Kobori M; Nakamura H
Proteins; 2008 Nov; 73(3):608-20. PubMed ID: 18473362
[TBL] [Abstract][Full Text] [Related]
57. Probing a protein-protein interaction by in vitro evolution.
Thom G; Cockroft AC; Buchanan AG; Candotti CJ; Cohen ES; Lowne D; Monk P; Shorrock-Hart CP; Jermutus L; Minter RR
Proc Natl Acad Sci U S A; 2006 May; 103(20):7619-24. PubMed ID: 16684878
[TBL] [Abstract][Full Text] [Related]
58. Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.
Neumann F; Sturm C; Hülsmeyer M; Dauth N; Guillaume P; Luescher IF; Pfreundschuh M; Held G
Immunol Lett; 2009 Aug; 125(2):86-92. PubMed ID: 19524620
[TBL] [Abstract][Full Text] [Related]
59. Isolation and characterization of human neutralizing antibodies to rabies virus derived from a recombinant immune antibody library.
Houimel M; Dellagi K
J Virol Methods; 2009 Nov; 161(2):205-15. PubMed ID: 19559727
[TBL] [Abstract][Full Text] [Related]
60. In vitro evolution of a hyperstable Gbeta1 variant.
Wunderlich M; Schmid FX
J Mol Biol; 2006 Oct; 363(2):545-57. PubMed ID: 16978647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
